Exchange: NASDAQ·Updated 04:33 PM EDT
ALNY logo

ALNY Alnylam Pharmaceuticals Inc

$250.20
$0.60
(0.23%)
Today
Closed $255.36
$5.16
(2.02%)
After Hours
EarningsOct 29
Mkt Cap$34.25B
Vol1.11M

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.
54

Neutral Sentiment

How do you feel about ALNY?

Advertisement|Remove ads.